Skip to main content
Download PDF

Volume 1 Supplement 1

1st Scientific Meeting of the Head and Neck Optical Diagnostics Society

Integrin αvβ6 promotes TGF-β1-dependent myofibroblastic transdifferentiation in oral submucous fibrosis

Head & Neck Oncology volume 1, Article number: P14 (2009) Cite this article

Introduction

Oral submucous fibrosis (OSF) is a chronic progressive fibrosing disorder of the oral cavity. Commonly in fibrosis, TGF-β1 promotes the transdifferentiation of fibroblasts into α-smooth muscle actin (SMA)-secreting myofibroblasts. Integrin αvβ6 is not detectable on normal oral keratinocytes but is upregulated during tissue remodelling. αvβ6 is a key activator of TGF-β1 through its interaction with its latency associated peptide.

Objective

To investigate the role of αvβ6 integrin in the pathogenesis of OSF.

Methods

αvβ6 expression was examined in 41 OSF cases compared with 14 cases of fibroepithelial hyperplasia by immunohistochemistry. TGF-β1 activation assays were carried out using a keratinocyte cell line expressing high levels of αvβ6 (VB6). VB6 cells were co-cultured with HFFF2 fibrblasts and SMA expression examined by Western blotting and confocal microscopy.

Results and conclusion

αvβ6 was highly expressed in 54% of OSF cases. αvβ6 activated TGF-β1, which was significantly reduced by antibody blockade. Co-culture experiments revealed markedly increased SMA expression by fibroblasts, indicating myofibroblast transdifferentiation, which was αvβ6-dependent. In vitro findings were confirmed by immunochemistry, which demonstrated SMA-. pSmad2 and Smad4-positive myofibroblasts in OSF connective tissue. Finally, treating oral keratinocytes with the areca nut alkaloid arecoline upregulated αvβ6 expression. In summary, we show that αvβ6 integrin is strongly expressed in OSF, and that it promotes myofibroblast transdifferentiation by activating TGF-β1. These data suggest a possible mechanism for the chronic fibrosis seen in OSF.

Author information

Affiliations

  1. Centre for Tumour Biology, Institute of Cancer, Barts & The London School of Medicine & Dentistry, London, UK

    Karwan A Moutasim, Veronica Jenei, Sarah Dickinson & Gareth J Thomas

  2. Clinical and Diagnostic Oral Sciences, Institute of Dentistry, Barts & The London School of Medicine & Dentistry, London, UK

    Karwan A Moutasim, Daud Mirza, Wanninayaka Tilakaratne & Gareth J Thomas

  3. UCL Cancer Institute, London, UK

    Dan Marsh

Authors
  1. Karwan A Moutasim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daud Mirza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dan Marsh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Veronica Jenei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sarah Dickinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wanninayaka Tilakaratne
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gareth J Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karwan A Moutasim.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Moutasim, K.A., Mirza, D., Marsh, D. et al. Integrin αvβ6 promotes TGF-β1-dependent myofibroblastic transdifferentiation in oral submucous fibrosis. Head Neck Oncol 1, P14 (2009). https://doi.org/10.1186/1758-3284-1-S1-P14

Download citation

Keywords

  • Alkaloid
  • Oral Cavity
  • Keratinocyte Cell
  • Oral Submucous Fibrosis
  • Oral Keratinocytes

Head & Neck Oncology

ISSN: 1758-3284